BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture [Yahoo! Finance]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Yahoo! Finance
VANCOUVER, BC and MADISON, Wis. April 22, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF ) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce an expansion of the Fields of Use in the current License Agreement to include commercial aquaculture, plus the farm-raised fish market. With this expansion in the Fields of Use, SpayVac-for-Wildlife's markets now include its no-booster fertility-control vaccines for aquaculture as well as overabundant feral/wild/invasive animals, and select production and companion animals, which significantly increases SpayVac's global revenue potential. The global market for farm-raised Atlantic salmon and rainbow trout represents a significant commercial opportunity for SpayVac. According to Seafish , a UK-based public body supporting the aquaculture industry, the annual harvest of these two species totals approximately 3.28 million metric tons, equating to an estimated 800 million individual fi
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Zoetis (NYSE:ZTS) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
- Veterinary Medicine Market Size to Hit USD 98.51 Billion by 2033, Growing at a CAGR of 8.11% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. [Yahoo! Finance]Yahoo! Finance
- Zoetis (NYSE:ZTS) was given a new $160.00 price target on by analysts at Morgan Stanley.MarketBeat
- Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
ZTS
Earnings
- 11/4/25 - Beat
ZTS
Sec Filings
- 12/18/25 - Form 8-K
- 12/11/25 - Form 8-K
- 12/2/25 - Form 3
- ZTS's page on the SEC website